SCHEMBL17865083

SCHEMBL17865083

CC(CC(=O)NO)C1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.50
MMP2 P08253 4/20 0.50
MMP3 P08254 2/20 0.50
MMP9 P14780 1/20 0.50
MMP14 P50281 1/20 0.50
LTA4H P09960 1/20 0.47
MMP7 P09237 1/20 0.44
MMP12 P39900 1/20 0.44
ECE1 P42892 1/20 0.44
MMP13 P45452 1/20 0.44
REN P00797 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
EPHX1 P07099 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769503 0.79 ALDH1A1 (0.42) MMP2EPHX1HPGDKMT2ACA12
SCHEMBL1208925 0.78 ALDH1A1 (0.55) MMP2RENEPHX1HPGDCA12
SCHEMBL6808670 0.78 ALDH1A1 (0.55) MMP2RENEPHX1HPGDCA12
SCHEMBL4742218 0.78 ALDH1A1 (0.42) MMP2EPHX1HPGDKMT2ACA12
SCHEMBL17715691 0.78 ALDH1A1 (0.42) MMP2EPHX1HPGDKMT2ACA12
SCHEMBL8651989 0.78 ALDH1A1 (0.55) MMP2RENEPHX1HPGDCA12
SCHEMBL17865084 0.77 EPHX2 (0.46) MMP2EPHX1HPGDKMT2ACA12
SCHEMBL6804343 0.76 ALDH1A1 (0.40) MMP2EPHX1HPGDKMT2ACA12
SCHEMBL13999779 0.76 EPHX1 (0.48) MMP2EPHX1CA12CA1CA2
SCHEMBL931422 0.76 EPHX1 (0.48) MMP2EPHX1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10369130-B2 Antibacterial compounds AZIEN DE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2019-08-06 US disclosed
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-28 US disclosed
WO-2016096631-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10369130-B2 Antibacterial compounds MRPL21, CLPP, NRDC MMP1 2826/4885MMP2 2023/4885MMP3 1452/4885
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS MRPL21, CLPP, NRDC MMP1 2826/4885MMP2 2023/4885MMP3 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.